Global Viral Testing Market Research Report 2021

1 Viral Testing Market Overview

• 1.1 Product Overview and Scope of Viral Testing
• 1.2 Viral Testing Segment by Type
  • 1.2.1 Global Viral Testing Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Direct Fluorescent Antibody (DFA) Test
  • 1.2.3 Immunochromatographic Assay
  • 1.2.4 RT-PCR-Based Test
  • 1.2.5 Agglutination Assay
  • 1.2.6 Flow-Through Assay
  • 1.2.7 Solid-Phase Assay
• 1.3 Viral Testing Segment by Application
  • 1.3.1 Viral Testing Sales Comparison by Application: (2021-2027)
  • 1.3.2 Laboratory
  • 1.3.3 Hospital
  • 1.3.4 Home Care
  • 1.3.5 Academic Institute
• 1.4 Global Viral Testing Market Size Estimates and Forecasts
  • 1.4.1 Global Viral Testing Revenue 2016-2027
  • 1.4.2 Global Viral Testing Sales 2016-2027
  • 1.4.3 Viral Testing Market Size by Region: 2016 Versus 2021 Versus 2027

2 Viral Testing Market Competition by Manufacturers

• 2.1 Global Viral Testing Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Viral Testing Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Viral Testing Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Viral Testing Manufacturing Sites, Area Served, Product Type
• 2.5 Viral Testing Market Competitive Situation and Trends
  • 2.5.1 Viral Testing Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Viral Testing Players Market Share by Revenue
  • 2.5.3 Global Viral Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Viral Testing Retrospective Market Scenario by Region

• 3.1 Global Viral Testing Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Viral Testing Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Viral Testing Market Facts & Figures by Country
  • 3.3.1 North America Viral Testing Sales by Country
  • 3.3.2 North America Viral Testing Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Viral Testing Market Facts & Figures by Country
  • 3.4.1 Europe Viral Testing Sales by Country
  • 3.4.2 Europe Viral Testing Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Viral Testing Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Viral Testing Sales by Region
  • 3.5.2 Asia Pacific Viral Testing Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Viral Testing Market Facts & Figures by Country
  • 3.6.1 Latin America Viral Testing Sales by Country
  • 3.6.2 Latin America Viral Testing Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Viral Testing Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Viral Testing Sales by Country
  • 3.7.2 Middle East and Africa Viral Testing Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Viral Testing Historic Market Analysis by Type

• 4.1 Global Viral Testing Sales Market Share by Type (2016-2021)
• 4.2 Global Viral Testing Revenue Market Share by Type (2016-2021)
• 4.3 Global Viral Testing Price by Type (2016-2021)

5 Global Viral Testing Historic Market Analysis by Application

• 5.1 Global Viral Testing Sales Market Share by Application (2016-2021)
• 5.2 Global Viral Testing Revenue Market Share by Application (2016-2021)
• 5.3 Global Viral Testing Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Roche
  • 6.1.1 Roche Corporation Information
  • 6.1.2 Roche Description and Business Overview
  • 6.1.3 Roche Viral Testing Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Roche Product Portfolio
  • 6.1.5 Roche Recent Developments/Updates
• 6.2 Agilent Technologies
  • 6.2.1 Agilent Technologies Corporation Information
  • 6.2.2 Agilent Technologies Description and Business Overview
  • 6.2.3 Agilent Technologies Viral Testing Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Agilent Technologies Product Portfolio
  • 6.2.5 Agilent Technologies Recent Developments/Updates
• 6.3 Thermo Fisher Scientific
  • 6.3.1 Thermo Fisher Scientific Corporation Information
  • 6.3.2 Thermo Fisher Scientific Description and Business Overview
  • 6.3.3 Thermo Fisher Scientific Viral Testing Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Thermo Fisher Scientific Product Portfolio
  • 6.3.5 Thermo Fisher Scientific Recent Developments/Updates
• 6.4 QIAGEN International
  • 6.4.1 QIAGEN International Corporation Information
  • 6.4.2 QIAGEN International Description and Business Overview
  • 6.4.3 QIAGEN International Viral Testing Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 QIAGEN International Product Portfolio
  • 6.4.5 QIAGEN International Recent Developments/Updates
• 6.5 Lonza
  • 6.5.1 Lonza Corporation Information
  • 6.5.2 Lonza Description and Business Overview
  • 6.5.3 Lonza Viral Testing Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Lonza Product Portfolio
  • 6.5.5 Lonza Recent Developments/Updates
• 6.6 Wuxi Pharmatech (Cayman)
  • 6.6.1 Wuxi Pharmatech (Cayman) Corporation Information
  • 6.6.2 Wuxi Pharmatech (Cayman) Description and Business Overview
  • 6.6.3 Wuxi Pharmatech (Cayman) Viral Testing Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Wuxi Pharmatech (Cayman) Product Portfolio
  • 6.6.5 Wuxi Pharmatech (Cayman) Recent Developments/Updates
• 6.7 Merck
  • 6.6.1 Merck Corporation Information
  • 6.6.2 Merck Description and Business Overview
  • 6.6.3 Merck Viral Testing Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Merck Product Portfolio
  • 6.7.5 Merck Recent Developments/Updates
• 6.8 Eurofins Scientific
  • 6.8.1 Eurofins Scientific Corporation Information
  • 6.8.2 Eurofins Scientific Description and Business Overview
  • 6.8.3 Eurofins Scientific Viral Testing Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Eurofins Scientific Product Portfolio
  • 6.8.5 Eurofins Scientific Recent Developments/Updates
• 6.9 General Electric
  • 6.9.1 General Electric Corporation Information
  • 6.9.2 General Electric Description and Business Overview
  • 6.9.3 General Electric Viral Testing Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 General Electric Product Portfolio
  • 6.9.5 General Electric Recent Developments/Updates
• 6.10 Danaher
  • 6.10.1 Danaher Corporation Information
  • 6.10.2 Danaher Description and Business Overview
  • 6.10.3 Danaher Viral Testing Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Danaher Product Portfolio
  • 6.10.5 Danaher Recent Developments/Updates
• 6.11 Bio-Rad Laboratories
  • 6.11.1 Bio-Rad Laboratories Corporation Information
  • 6.11.2 Bio-Rad Laboratories Viral Testing Description and Business Overview
  • 6.11.3 Bio-Rad Laboratories Viral Testing Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Bio-Rad Laboratories Product Portfolio
  • 6.11.5 Bio-Rad Laboratories Recent Developments/Updates
• 6.12 BD
  • 6.12.1 BD Corporation Information
  • 6.12.2 BD Viral Testing Description and Business Overview
  • 6.12.3 BD Viral Testing Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 BD Product Portfolio
  • 6.12.5 BD Recent Developments/Updates
• 6.13 Biospherix
  • 6.13.1 Biospherix Corporation Information
  • 6.13.2 Biospherix Viral Testing Description and Business Overview
  • 6.13.3 Biospherix Viral Testing Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Biospherix Product Portfolio
  • 6.13.5 Biospherix Recent Developments/Updates
• 6.14 Novogene Corporation
  • 6.14.1 Novogene Corporation Corporation Information
  • 6.14.2 Novogene Corporation Viral Testing Description and Business Overview
  • 6.14.3 Novogene Corporation Viral Testing Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Novogene Corporation Product Portfolio
  • 6.14.5 Novogene Corporation Recent Developments/Updates
• 6.15 Sartorius
  • 6.15.1 Sartorius Corporation Information
  • 6.15.2 Sartorius Viral Testing Description and Business Overview
  • 6.15.3 Sartorius Viral Testing Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Sartorius Product Portfolio
  • 6.15.5 Sartorius Recent Developments/Updates

7 Viral Testing Manufacturing Cost Analysis

• 7.1 Viral Testing Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Viral Testing
• 7.4 Viral Testing Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Viral Testing Distributors List
• 8.3 Viral Testing Customers

9 Viral Testing Market Dynamics

• 9.1 Viral Testing Industry Trends
• 9.2 Viral Testing Growth Drivers
• 9.3 Viral Testing Market Challenges
• 9.4 Viral Testing Market Restraints

10 Global Market Forecast

• 10.1 Viral Testing Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Viral Testing by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Viral Testing by Type (2022-2027)
• 10.2 Viral Testing Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Viral Testing by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Viral Testing by Application (2022-2027)
• 10.3 Viral Testing Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Viral Testing by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Viral Testing by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List